Growth hormone does not stimulate early healing in rat tendons

Area of Science:

• Biomedical Engineering
• Orthopedics
• Endocrinology

Background:

• Growth Hormone (GH) is crucial for bone growth and fracture repair, primarily by increasing Insulin-like Growth Factor 1 (IGF-1) levels.
• Local IGF-1 application has shown promise in stimulating tendon healing.
• The systemic effects of GH on tendon repair remain largely unexplored.

Purpose of the Study:

• To investigate the hypothesis that systemic Growth Hormone administration enhances tendon healing.
• To evaluate the impact of GH on tendon repair strength under varying mechanical loading conditions.

Main Methods:

• Rat Achilles tendons were transected and allowed to heal.
• Four experimental groups were established, with two groups receiving botulinum toxin A (Botox) to induce muscle paralysis and reduce tendon loading.
• Animals were randomized to receive twice-daily injections of either Growth Hormone or saline for 10 days, followed by mechanical testing of the healing tendons.

Main Results:

• Botox-induced muscle paralysis significantly reduced healing tendon strength by approximately two-thirds.
• Growth Hormone administration increased bone length in unloaded limbs and bone weight in loaded limbs.
• No significant increase in the strength of healing tendons was observed in GH-treated groups, irrespective of mechanical loading status.

Conclusions:

• Systemic administration of Growth Hormone does not appear to stimulate tendon healing or improve the mechanical strength of repairing tendons.
• GH's known anabolic effects on bone and other tissues do not translate to enhanced tendon repair in this model.
• Further research is needed to understand the specific mechanisms governing tendon healing and potential therapeutic interventions.